From https://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
Novartis
Based in Basel, Switzerland, Novartis makes prescription and generic drugs, eye care products, vaccines and diagnostics. In September 2010, Novartis agreed to pay $420 million to settle allegations of improper marketing of six drugs. It pleaded guilty to a misdemeanor of off-label promotion involving Trileptal as an anti-epileptic drug.
Novartis reports payments to physicians for speaking and speaker training after October 2010. Its first report covers the period of October 2010 to September 2011. Its 2012 report includes meals, travel, consulting, educational items, research and speaking fees. Data from October to December 2011 is not included in this tool.
Novartis's 2013 U.S. sales: $19 billion. Source: IMS Health.
See all Novartis payments, or visit Novartis's transparency page.
Notable drugs
- Diovan/Co–Diovan (hypertension)
- Gleevec (chronic myeloid leukemia)
- Sandostatin (excess growth hormone)
- Ritalin/Focalin (ADHD)
- Gilenya (relapsing multiple sclerosis)
- Exelon/Exelon Patch (Alzheimer’s disease)
- Exforge (hypertension)
- Tasigna (chronic myeloid leukemia)
- Afinitor (advanced kidney cancer, breast cancer, pancreatic cancer, brain cancer)
- Cataflam (NSAID)
- Clozaril (treatment-resistant Schizophrenia)
Payment Reports
2010 Oct. to 2011 Sept.
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $24,830,517 | $24,830,517 |
| $24,830,517 | $24,830,517 |
2012 Jan. to Dec.
| Avg. Quarterly | Total | |
|---|---|---|
| Research | $15,288,411 | $61,153,643 |
| Speaking | $3,709,123 | $14,836,491 |
| Meals | $1,403,556 | $5,614,225 |
| Consulting | $1,044,864 | $4,179,456 |
| Travel | $1,031,174 | $4,124,696 |
| Items, Gifts | $257,820 | $1,031,281 |
| Adjustment | -$1,246 | -$4,984 |
| $22,733,702 | $90,934,808 |
2013 Jan. to Dec.
| Avg. Quarterly | Total | |
|---|---|---|
| Research | $14,034,850 | $56,139,400 |
| Speaking | $3,184,506 | $12,738,025 |
| Meals | $1,347,482 | $5,389,929 |
| Consulting | $1,190,656 | $4,762,622 |
| Travel | $955,172 | $3,820,687 |
| Items, Gifts | $135 | $540 |
| $20,712,801 | $82,851,203 |
Total Payments by State
| State | Total |
|---|---|
| Texas | $18,225,355 |
| California | $16,925,526 |
| New York | $15,488,183 |
| Florida | $15,336,399 |
| Ohio | $12,122,108 |
| Massachusetts | $9,439,999 |
| Michigan | $9,303,769 |
| Georgia | $9,212,905 |
| Maryland | $8,030,782 |
| Illinois | $7,551,224 |
| North Carolina | $6,935,119 |
| Pennsylvania | $6,243,391 |
| New Jersey | $5,331,442 |
| Tennessee | $4,847,268 |
| Missouri | $4,289,031 |
| Nebraska | $4,239,261 |
| Colorado | $3,893,336 |
| Virginia | $3,683,807 |
| Alabama | $3,674,021 |
| Minnesota | $3,018,493 |
| Indiana | $2,680,922 |
| Washington | $2,638,128 |
| Connecticut | $2,329,325 |
| South Carolina | $2,215,485 |
| Louisiana | $2,055,964 |
| Oregon | $1,706,989 |
| Arizona | $1,677,857 |
| Wisconsin | $1,533,836 |
| Kentucky | $1,428,520 |
| Kansas | $1,280,550 |
| Iowa | $1,186,684 |
| Idaho | $881,550 |
| Oklahoma | $833,360 |
| Mississippi | $791,370 |
| Utah | $750,551 |
| New Mexico | $702,951 |
| Puerto Rico | $683,640 |
| New Hampshire | $617,490 |
| Vermont | $607,479 |
| Nevada | $605,263 |
| Rhode Island | $543,538 |
| Arkansas | $538,699 |
| Hawaii | $468,655 |
| Delaware | $427,477 |
| West Virginia | $407,442 |
| North Dakota | $337,435 |
| Montana | $295,595 |
| South Dakota | $178,472 |
| Maine | $148,253 |
| District of Columbia | $138,754 |
| Wyoming | $75,383 |
| Alaska | $54,338 |
| [Unknown State] | $2,203 |
What Companies Disclose
See which services pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.
